Template:PDB Gallery/6714

• 1a07: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE)

  1a07: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE)

• 1a08: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

  1a08: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

• 1a09: C-src (SH2 domain) complexed with ace-formyl phosphotyr-glu-(n,n-dipentyl amine)

  1a09: C-src (SH2 domain) complexed with ace-formyl phosphotyr-glu-(n,n-dipentyl amine)

• 1a1a: C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

  1a1a: C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

• 1a1b: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

  1a1b: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE)

• 1a1c: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3-CYCLOPENTYL))

  1a1c: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3-CYCLOPENTYL))

• 1a1e: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE)

  1a1e: C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE)

• 1bkl: SELF-ASSOCIATED APO SRC SH2 DOMAIN

  1bkl: SELF-ASSOCIATED APO SRC SH2 DOMAIN

• 1bkm: COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX

  1bkm: COCRYSTAL STRUCTURE OF D-AMINO ACID SUBSTITUTED PHOSPHOPEPTIDE COMPLEX

• 1f1w: SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN

  1f1w: SRC SH2 THREF1TRP MUTANT COMPLEXED WITH THE PHOSPHOPEPTIDE S(PTR)VNVQN

• 1f2f: SRC SH2 THREF1TRP MUTANT

  1f2f: SRC SH2 THREF1TRP MUTANT

• 1fmk: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC

  1fmk: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC

• 1hcs: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX

  1hcs: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX

• 1hct: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX

  1hct: NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX

• 1is0: Crystal Structure of a Complex of the Src SH2 Domain with Conformationally Constrained Peptide Inhibitor

  1is0: Crystal Structure of a Complex of the Src SH2 Domain with Conformationally Constrained Peptide Inhibitor

• 1kc2: structure of the triple (Lys(beta)D3Ala, Asp(beta)C8Ala, AspCD2Ala) mutant of the Src SH2 domain bound to the PQpYEEIPI peptide

  1kc2: structure of the triple (Lys(beta)D3Ala, Asp(beta)C8Ala, AspCD2Ala) mutant of the Src SH2 domain bound to the PQpYEEIPI peptide

• 1ksw: Structure of Human c-Src Tyrosine Kinase (Thr338Gly Mutant) in Complex with N6-benzyl ADP

  1ksw: Structure of Human c-Src Tyrosine Kinase (Thr338Gly Mutant) in Complex with N6-benzyl ADP

• 1nlo: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE

  1nlo: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE

• 1nlp: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE

  1nlp: STRUCTURE OF SIGNAL TRANSDUCTION PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE

• 1nzl: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYEpYIPI

  1nzl: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYEpYIPI

• 1nzv: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYIpYVPA

  1nzv: Crystal Structure of Src SH2 domain bound to doubly phosphorylated peptide PQpYIpYVPA

• 1o41: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300.

  1o41: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300.

• 1o42: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843.

  1o42: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843.

• 1o43: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129.

  1o43: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129.

• 1o44: Crystal structure of sh2 in complex with ru85052

  1o44: Crystal structure of sh2 in complex with ru85052

• 1o45: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687.

  1o45: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687.

• 1o46: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395.

  1o46: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395.

• 1o47: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209.

  1o47: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209.

• 1o48: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.

  1o48: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.

• 1o49: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.

  1o49: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493.

• 1o4a: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197.

  1o4a: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197.

• 1o4b: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876.

  1o4b: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876.

• 1o4c: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.

  1o4c: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE.

• 1o4d: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262.

  1o4d: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262.

• 1o4e: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299.

  1o4e: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299.

• 1o4f: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073.

  1o4f: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073.

• 1o4g: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59.

  1o4g: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59.

• 1o4h: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072.

  1o4h: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072.

• 1o4i: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219.

  1o4i: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219.

• 1o4j: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24.

  1o4j: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24.

• 1o4k: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN.

  1o4k: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN.

• 1o4l: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2.

  1o4l: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2.

• 1o4m: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID.

  1o4m: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID.

• 1o4n: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID.

  1o4n: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID.

• 1o4o: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE.

  1o4o: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE.

• 1o4p: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791.

  1o4p: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791.

• 1o4q: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256.

  1o4q: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256.

• 1o4r: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783.

  1o4r: CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783.

• 1p13: Crystal Structure of the Src SH2 Domain Complexed with Peptide (SDpYANFK)

  1p13: Crystal Structure of the Src SH2 Domain Complexed with Peptide (SDpYANFK)

• 1prl: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

  1prl: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

• 1prm: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

  1prm: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

• 1qwe: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND APP12

  1qwe: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND APP12

• 1qwf: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND VSL12

  1qwf: C-SRC SH3 DOMAIN COMPLEXED WITH LIGAND VSL12

• 1rlp: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

  1rlp: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

• 1rlq: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

  1rlq: TWO BINDING ORIENTATIONS FOR PEPTIDES TO SRC SH3 DOMAIN: DEVELOPMENT OF A GENERAL MODEL FOR SH3-LIGAND INTERACTIONS

• 1sha: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES

  1sha: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES

• 1shb: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES

  1shb: CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES

• 1shd: PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS

  1shd: PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS

• 1skj: COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX

  1skj: COCRYSTAL STRUCTURE OF UREA-SUBSTITUTED PHOSPHOPEPTIDE COMPLEX

• 1spr: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS

  1spr: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS

• 1sps: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS

  1sps: BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS

• 1srl: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN

  1srl: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN

• 1srm: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN

  1srm: 1H AND 15N ASSIGNMENTS AND SECONDARY STRUCTURE OF THE SRC SH3 DOMAIN

• 1y57: Structure of unphosphorylated c-Src in complex with an inhibitor

  1y57: Structure of unphosphorylated c-Src in complex with an inhibitor

• 1yi6: C-term tail segment of human tyrosine kinase (258-533)

  1yi6: C-term tail segment of human tyrosine kinase (258-533)

• 1yoj: Crystal structure of Src kinase domain

  1yoj: Crystal structure of Src kinase domain

• 1yol: Crystal structure of Src kinase domain in complex with CGP77675

  1yol: Crystal structure of Src kinase domain in complex with CGP77675

• 1yom: Crystal structure of Src kinase domain in complex with Purvalanol A

  1yom: Crystal structure of Src kinase domain in complex with Purvalanol A

• 2bdf: Src kinase in complex with inhibitor AP23451

  2bdf: Src kinase in complex with inhibitor AP23451

• 2bdj: Src kinase in complex with inhibitor AP23464

  2bdj: Src kinase in complex with inhibitor AP23464

• 2h8h: Src kinase in complex with a quinazoline inhibitor

  2h8h: Src kinase in complex with a quinazoline inhibitor

• 2hwo: Crystal structure of Src kinase domain in complex with covalent inhibitor

  2hwo: Crystal structure of Src kinase domain in complex with covalent inhibitor

• 2hwp: Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393

  2hwp: Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393

• 2oiq: Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.

  2oiq: Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.

• 2ptk: CHICKEN SRC TYROSINE KINASE

  2ptk: CHICKEN SRC TYROSINE KINASE

• 2src: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP

  2src: CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP